/b/veterinary-news/posts/bsava-congress-to-examine-hypoglycaemic-agent-for-feline-diabetes Following the launch of two oral hypoglycaemic agents (SGLT2-inhibitors) for feline diabetes, Bexacat (bexagliflozin, Elanco) in the US and Senvelgo ( Velagliflozin, Boehringer) in the UK and US, BSAVA Congress will be hosting a talk to explore how theyen-USTelligent Community 10